Skip to main content

MARSHALL WACE, LLP

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in RLMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,548,124
-$15,643,852 QoQ
Shares Held
2,246,839
-49.9% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 126 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. RLMD ranks #49 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,548,124 2,246,839
2026-03-31 $31,191,976 4,481,606
2025-12-31 $15,406,066 3,189,662
2025-09-30 $546,825 272,053
2025-06-30 $92,740 154,568
2024-09-30 $163,845 50,570
2024-06-30 $469,857 156,619
2024-03-31 $966,595 207,870
2023-12-31 $635,593 153,525
2022-09-30 $3,563,322 96,254